Summary of Purpose
The study investigates the effect of plasma myeloperoxidase (MPO) concentrations on HDL dysfunction during the acute stage of ischemic and haemorrhagic strokes.Read More →
The following dates are available for this trial. Trial information last updated on 18 December 2017.
|20 Oct 2017||8 Aug 2017||1 Oct 2018||1 Mar 2019||1 Dec 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- David COURET, MD
- Christine JUHEL, PHD